USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING
PLOS Biology · 11.05.2026 · 24 (5) · e3003796
DOI: 10.1371/journal.pbio.3003796 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 11.05.2026. Verfasst von Jiazheng Quan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, Marshall Laboratory of Biomedical Engineering, Institute of Biological Th…. Hauptthemen laut MEDLINE: Membrane Proteins, Ubiquitin-Specific Proteases, DEAD Box Protein 58. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
RIG-I and STING are critical for mediating the RIG-I and cGAS-STING signaling pathways that guard against viral infection. Here, we report that ubiquitin-specific peptidase 39 (USP39) positively regulates the RIG-I and cGAS-STING pathways to induce antiviral innate immunity in vitro and in vivo. The USP39 deficiency impaired the antiviral immune response of macrophages, leading to low type I IFNs expression, and high RNA and (e.g., VSV, H1N1 PR8) DNA virus (e.g., HSV-1) replication . Moreover, USP39-deficient mice were more sensitive to VSV or HSV-1 infection than control mice. Conversely, USP39 overexpression promoted the antiviral immune response. Mechanistically, we found that USP39 regulates RIG-I protein expression by promoting pre-RIG-I mRNA splicing and maturation. In addition, we also revealed that USP39 interacts with and stabilizes STING protein by deubiquitinating K48-linked polyubiquitin of STING at K288. These data show that USP39 positively regulates RNA and DNA-virus-induced RIG-I and cGAS-STING signaling, respectively, by promoting post-transcriptional control of RIG-I and stabilization of STING. These data provide new insights and potential therapeutic targets to control viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, Marshall Laboratory of Biomedical Engineering, Institute of Biological Therapy, Shenzhen University Medical School, Shenzhen University, Shenzh…
- Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
- Institute of Immunology, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
ORCID-Profile: Weilin Chen
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Program
- Medical Science and Technology Foundation of Guangdong Province
- Program for Youzuzhikeyan of Shenzhen University
Zitieren
APA
Quan, J., Zhao, X., Chen, S., Li, H., Chen, W., Di, Q., Li, X., Zhao, J., Wu, H., Chen, J., Xiao, Y., Wu, Z., & Chen, W. (2026). USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING. PLOS Biology, 24(5), e3003796. https://doi.org/10.1371/journal.pbio.3003796
Vancouver
Quan J, Zhao X, Chen S, Li H, Chen W, Di Q, et al. USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING. PLOS Biology. 2026;24(5):e3003796. doi:10.1371/journal.pbio.3003796
BibTeX
@article{Quan2026,
author = {Quan, Jiazheng and Zhao, Xibao and Chen, Shaoying and Li, Hongrui and Chen, Wei and Di, Qianqian and Li, Xunwei and Zhao, Jiajing and Wu, Han and Chen, Jin and Xiao, Yue and Wu, Zherui and Chen, Weilin},
title = {USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING},
journal = {PLOS Biology},
year = {2026},
volume = {24},
number = {5},
pages = {e3003796},
doi = {10.1371/journal.pbio.3003796}
}
EUVIMED